P. Martorell

Biopolis (Spain)

Health Outcomes Studied

• Improved Insulin Sensitivity
• Increased Adiponectin Levels
• Increased Fecal Acetate Levels
• Reduced Body Mass Index
• Reduced Body Weight
• Reduced Diastolic Blood Pressure
• Reduced Tumor Necrosis Factor Alpha
• Reduced Visceral Fat
• Reduced Waist Circumference
• Reduced Waist-to-Height Ratio

Papers (8)

• 2023
  Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic Bacillus clausii CSI0810.3390/microorganisms11020240
• 2023
  Evaluation of Bacillus clausii CSI08, Bacillus megaterium MIT411 and a Bacillus cocktail on gastrointestinal health: a randomised, double-blind, placebo-controlled pilot study.10.3920/BM2022.0117
• 2021
  Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF‐1 pathway10.1111/1751-7915.13769
• 2020
  An Infant Milk Formula Supplemented with Heat-Treated Probiotic Bifidobacterium animalis subsp. lactis CECT 8145, Reduces Fat Deposition in C. elegans and Augments Acetate and Lactate in a Fermented Infant Slurry10.3390/foods9050652
• 2018
  Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.10.3920/BM2017.0141
• 2018
  Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial10.1038/s41366-018-0220-0
• 2016Primary author
  Probiotic Strain Bifidobacterium animalis subsp. lactis CECT 8145 Reduces Fat Content and Modulates Lipid Metabolism and Antioxidant Response in Caenorhabditis elegans.10.1021/acs.jafc.5b05934
• 2014
  Draft Genome Sequence of Bifidobacterium animalis subsp. lactis Strain CECT 8145, Able To Improve Metabolic Syndrome In Vivo10.1128/genomeA.00183-14